These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 17486433)

  • 41. The second Leicester survey of memory clinics in the British Isles.
    Lindesay J; Marudkar M; van Diepen E; Wilcock G
    Int J Geriatr Psychiatry; 2002 Jan; 17(1):41-7. PubMed ID: 11802229
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The animal models of dementia and Alzheimer's disease for pre-clinical testing and clinical translation.
    Anand A; Banik A; Thakur K; Masters CL
    Curr Alzheimer Res; 2012 Nov; 9(9):1010-29. PubMed ID: 22698073
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Memory-enhancing drugs: a molecular perspective.
    Monti B; Contestabile A
    Mini Rev Med Chem; 2009 Jun; 9(7):769-81. PubMed ID: 19519502
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Current and future clinical trials for Alzheimer's disease: evolving ethical concerns.
    Issa AM; Keyserlingk EW
    Prog Neuropsychopharmacol Biol Psychiatry; 2000 Nov; 24(8):1229-49. PubMed ID: 11125851
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Novel drug candidates targeting Alzheimer's disease: ethical challenges with identifying the relevant patient population.
    Gustavsson E; Raaschou P; Lärfars G; Sandman L; Juth N
    J Med Ethics; 2021 Sep; 47(9):608-614. PubMed ID: 34117127
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ethical issues in early diagnosis and prevention of Alzheimer disease.
    Whitehouse PJ
    Dialogues Clin Neurosci; 2019 Mar; 21(1):101-108. PubMed ID: 31607785
    [TBL] [Abstract][Full Text] [Related]  

  • 47. An organizing model for recent cognitive science work on the self.
    Pageler B
    Conscious Cogn; 2016 Oct; 45():37-46. PubMed ID: 27560835
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Human enhancement: Genetic engineering and evolution.
    Almeida M; Diogo R
    Evol Med Public Health; 2019; 2019(1):183-189. PubMed ID: 31620286
    [TBL] [Abstract][Full Text] [Related]  

  • 49. On normative judgments and ethics.
    Arandjelović O
    BMC Med Ethics; 2016 Nov; 17(1):75. PubMed ID: 27876015
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dementia Improvement after Plasma Exchange for Familial Hypercholesterolemia.
    Orehek AJ
    Case Rep Neurol Med; 2016; 2016():6121878. PubMed ID: 27672461
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Translational issues with the development of cognition enhancing drugs.
    Blokland A; van Goethem N; Heckman P; Schreiber R; Prickaerts J
    Front Neurol; 2014; 5():190. PubMed ID: 25309509
    [No Abstract]   [Full Text] [Related]  

  • 52. Lifestyle improvement or anti-dementia drugs in Alzheimer's disease.
    Niwa F; Mizuno T; Nakagawa M
    Curr Med Res Opin; 2019 May; 35(5):925. PubMed ID: 30724624
    [No Abstract]   [Full Text] [Related]  

  • 53. Recognition for ego-involved materials.
    TRESSELT ME; LEVY B
    J Psychol; 1949 Jan; 27(First Half):73-8. PubMed ID: 18107104
    [No Abstract]   [Full Text] [Related]  

  • 54. The effect of NAD-299 and TCB-2 on learning and memory, hippocampal BDNF levels and amyloid plaques in Streptozotocin-induced memory deficits in male rats.
    Afshar S; Shahidi S; Rohani AH; Komaki A; Asl SS
    Psychopharmacology (Berl); 2018 Oct; 235(10):2809-2822. PubMed ID: 30027497
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Young Blood Rejuvenates Old Bodies: A Call for Reflection when Moving from Mice to Men.
    Hofmann B
    Transfus Med Hemother; 2018 Jan; 45(1):67-71. PubMed ID: 29593463
    [TBL] [Abstract][Full Text] [Related]  

  • 56. How Realistic Are the Scientific Assumptions of the Neuroenhancement Debate? Assessing the Pharmacological Optimism and Neuroenhancement Prevalence Hypotheses.
    Schleim S; Quednow BB
    Front Pharmacol; 2018; 9():3. PubMed ID: 29403383
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Limits to human enhancement: nature, disease, therapy or betterment?
    Hofmann B
    BMC Med Ethics; 2017 Oct; 18(1):56. PubMed ID: 29017486
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Neuro-enhancement. Brain doping].
    Förstl H
    Nervenarzt; 2009 Jul; 80(7):840-6. PubMed ID: 19565292
    [TBL] [Abstract][Full Text] [Related]  

  • 59. 'Self-care without a self': Alzheimer's disease and the concept of personal responsibility for health.
    Naue U
    Med Health Care Philos; 2008 Sep; 11(3):315-24. PubMed ID: 18288589
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Psychopharmacology and the self: an introduction to the theme.
    Svenaeus F
    Med Health Care Philos; 2007 Jun; 10(2):115-7. PubMed ID: 17497227
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.